Disseminated Neuroblastoma Completed Phase 1 Trials for Dinutuximab (DB09077)
Also known as: Disseminated Neuroblastoma (NB)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029099 (Disseminated Neuroblastoma) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00005576 | Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma | Treatment |